New Jersey: Mostly because it is discovered much later in life, pancreatic cancer is one of the deadliest types of the disease. For screens aimed at early detection, the current markers are too ambiguous and insensitive. Now, a study team has published a novel technique in the journal Angewandte Chemie that may result in a diagnosis that is far more exact and trustworthy. The methodology relies on the targeted identification of particular antibodies within blood specimens.
